Pompe Disease Market with COVID-19 Impact Analysis, By Route of Administration (Oral, Parenteral), By End-Use (Hospitals, Ambulatory Surgical Centers, Other), By Treatment Type (Substrate Reduction Therapy (SRT), Enzyme Replacement Therapy (ERT), Other), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Pompe Disease Market size was valued at USD 1322.23 Million in 2022, expanding at a CAGR of 4.2% from 2023 to 2030.
Pompe disease is a rare genetic ailment characterized by a lack of the enzyme acid alpha-glucosidase (GAA), which results in glycogen buildup inside cells. This glycogen accumulation has the greatest impact on muscles, decreasing their function and producing gradual weakening. Muscle weakness, breathing difficulties, and cardiac issues are common symptoms. The severity of the condition may vary from infantile beginnings, with potentially deadly cardiac and muscular consequences, to late-onset, with mostly muscle weakening. Pompe illness emphasizes the significance of early detection and continuing medical care in order to reduce the disease\'s effect on an individual\'s quality of life.
Pompe Disease Market- Market Dynamics
- Growing collaboration between pharmaceutical companies, research institutions, and patient advocacy groups to propel market demand
Growing cooperation among pharmaceutical firms, academic institutes, and patient advocacy organizations is a primary driver of progress in Pompe disease research and therapy. This partnership promotes the flow of information, experience, and resources, hence hastening the discovery of novel medicines. Companies are encouraged to invest in rare illness research by regulatory bodies\' orphan drug designation and incentives. Furthermore, patient advocacy organizations’ enhanced public awareness and fundraising activities produce cash for research and clinical trials. This collaborative effort improves knowledge of the illness\'s causes and allows the development of tailored therapeutics, eventually enhancing the prognosis and standard of life for Pompe disease patients.
Pompe Disease Market- Key Insights
- As per the analysis shared by our research analyst, the global Pompe Disease market is estimated to grow annually at a CAGR of around 4.2% over the forecast period (2023-2030)
- The Pompe Disease industry is projected to grow at a significant rate due to the growing collaboration between pharmaceutical companies, research institutions, and patient advocacy groups
- Based on Route of Administration segmentation, Parenteral was predicted to show maximum market share in the year 2022
- Based on End-Use segmentation, Hospitals was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Pompe Disease Market- Segmentation Analysis:
The Global Pompe Disease Market is segmented on the basis of Route of Administration, End-Use, Treatment Type, and Region.
The market is divided into two categories based on Route of Administration: Oral, Parenteral. The Parenteral sector dominates the market. Parenteral medicines for Pompe disease, a rare genetic illness, are nevertheless in high demand. The injection of enzyme replacement therapy (ERT) intravenously is a critical parenteral method to illness management. This therapy directly distributes the missing enzyme, treating glycogen buildup in cells and enhancing muscular performance in those who are impacted.
The market is divided into three categories based on End-Use: Hospitals, Ambulatory Surgical Centers, Other. The Hospitals sector dominates the market and is likely to maintain its dominance during the forecast period. Hospitals are critical in meeting the complicated demands of Pompe disease patients. The diagnosis, therapy, and management of this uncommon genetic condition fuel the need for hospital services. To enhance patients\' quality of life, hospitals provide specialized treatment such as enzyme replacement therapy (ERT), respiratory support, and multidisciplinary care teams.
Pompe Disease Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Because of growing knowledge, better diagnoses, and more advocacy activities, the need for effective medicines and full treatment for Pompe disease has grown in North America. Early detection and access to medications such as enzyme replacement therapy (ERT) are aided by the region\'s strong healthcare infrastructure and research capabilities. As prompt treatments enhance patient outcomes and quality of life, there is a growing need for specialized medical centers, healthcare personnel, and support services devoted to treating this uncommon genetic illness. Collaboration between pharmaceutical firms, research institutes, and patient organizations accelerates Pompe disease therapy and improves overall patient care in North America.
Pompe Disease Market- Competitive Landscape:
The competitive environment in Pompe disease research and treatment comprises a dynamic interaction between pharmaceutical corporations, research institutes, and advocacy organizations. Collaborations with academic institutions promote scientific breakthroughs. Patient advocacy organizations promote awareness, finance research, and advocate for regulatory assistance. The orphan drug designation stimulates competitiveness by giving incentives. As new technologies develop, corporations attempt to distinguish themselves via treatment effectiveness, accessibility, and patient support programs. This competitive atmosphere hastens development, diversifies therapy choices, and improves overall care for Pompe disease patients.
Recent Developments:
- In June 2023, Amicus Therapeutics, a patient-focused worldwide biotechnology company focused on developing and commercializing novel medicines for rare diseases, announced today that the European Commission (EC) has approved Opfolda (miglustat) 65mg capsules, an enzyme stabiliser of cipaglucosidase alfa, as a long-term enzyme replacement therapy for adults with late-onset Pompe disease.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL POMPE DISEASE MARKET KEY PLAYERS
- Sanofi Genzyme
- Amicus Therapeutics
- BioMarin Pharmaceutical
- Ultragenyx Pharmaceutical
- Audentes Therapeutics
- Avrobio
- Regenxbio
- EpiVax
- Selecta Biosciences
- Cytokinetics
- Adverum Biotechnologies
- Audentes Therapeutics
- JCR Pharmaceuticals
- Audentes Therapeutics
- Valerion Therapeutics
GLOBAL POMPE DISEASE MARKET, BY ROUTE OF ADMINISTRATION
- Oral
- Parenteral
GLOBAL POMPE DISEASE MARKET, BY END-USE
- Hospitals
- Ambulatory Surgical Centers
- Other
GLOBAL POMPE DISEASE MARKET, BY TREATMENT TYPE
- Substrate Reduction Therapy (SRT)
- Enzyme Replacement Therapy (ERT)
- Other
GLOBAL POMPE DISEASE MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Pompe Disease Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Pompe Disease Market Snippet by Route of Administration
2.1.2. Pompe Disease Market Snippet by Treatment Type
2.1.3. Pompe Disease Market Snippet by End-User
2.1.4. Pompe Disease Market Snippet by Country
2.1.5. Pompe Disease Market Snippet by Region
2.2. Competitive Insights
3. Pompe Disease Key Market Trends
3.1. Pompe Disease Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Pompe Disease Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Pompe Disease Market Opportunities
3.4. Pompe Disease Market Future Trends
4. Pompe Disease Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Pompe Disease Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Pompe Disease Market Landscape
6.1. Pompe Disease Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Pompe Disease Market – By Route of Administration
7.1. Overview
7.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
7.1.2. Oral
7.1.3. Parenteral
8. Pompe Disease Market – By Treatment Type
8.1. Overview
8.1.1. Segment Share Analysis, By Treatment Type, 2022 & 2030 (%)
8.1.2. Substrate Reduction Therapy (SRT)
8.1.3. Enzyme Replacement Therapy (ERT)
8.1.4. Other
9. Pompe Disease Market – By End-User
9.1. Overview
9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
9.1.2. Hospitals
9.1.3. Ambulatory Surgical Centers
9.1.4. Other
10. Pompe Disease Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Pompe Disease Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Pompe Disease Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Pompe Disease Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Pompe Disease Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Pompe Disease Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Pompe Disease Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Sanofi Genzyme
11.2.2. Amicus Therapeutics
11.2.3. BioMarin Pharmaceutical
11.2.4. Ultragenyx Pharmaceutical
11.2.5. Audentes Therapeutics
11.2.6. Avrobio
11.2.7. Regenxbio
11.2.8. EpiVax
11.2.9. Selecta Biosciences
11.2.10. Cytokinetics
11.2.11. Adverum Biotechnologies
11.2.12. Audentes Therapeutics
11.2.13. JCR Pharmaceuticals
11.2.14. Audentes Therapeutics
11.2.15. Valerion Therapeutics
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
